CR1 and rheumatic disorder: In patients with autoimmune hemolytic anemia (AIHA) and rheumatic diseases, RBC immunoprotein coating might take the form of immune complexes, since RBCs are known to express receptors for C3b (CR1) and have a key role in the transport and elimination of immune complexes containing IgG and C3b (24, 25).